Key result
HSD3B1 and CYP11A1 variants link to blood pressure, with CYP11A1 carriers showing lower LV mass.
Why the study?
Aldosterone synthesis is genetically regulated and somatic gene mutations contribute to pathological secretion, prompting a synthesis of evidence on the physiological and pathological roles of aldosterone in general metabolism and its genetic regulation.
Characterizing the genetic pathways governing aldosterone synthesis and degradation enables early identification of metabolic dysfunction within the renin-angiotensin-aldosterone system, facilitating timely clinical intervention for hypertension and related disorders prior to multi-organ involvement.
Answers are grounded in this paper and cite their sources.
Supports genetic insights into aldosterone pathways for hypertension; leaves open prospective validation before clinical adoption.
The physiological role of aldosterone is primarily aimed at maintaining sodium and water homeostasis of the body and preventing the loss of sodium ions and water. Its synthesis is genetically regulated primarily through the control of the aldosterone synthase gene expression, which is activated by angiotensin II and potassium in the zona glomerulosa of the adrenal cortex. Key somatic mutations in the genes contribute to pathological secretion. The aim of this study is to systematically review and synthesize evidence on the physiological and pathological roles of aldosterone in general metabolism and its genetic regulation. Materials and methods. We analyzed the current state of research on the effects of aldosterone on the development of various diseases and the genetic mechanisms underlying its regulation. A systematic review of current literature sources with a meta-analysis was conducted for the period from 2017 to 2026. The search was performed in the scientometric databases PubMed/MEDLINE, Embase, Scopus, Web of Science, and the Cochrane Library; Google Scholar and ProQuest Dissertations & Theses were additionally reviewed. MeSH/Emtree controlled vocabulary and free-text keywords were used: primary hyperaldosteronism, mineralocorticoid receptor, aldosterone metabolism, renin-angiotensin-aldosterone system, aldosterone metabolism disorders, genetic regulation of aldosterone. The review includes articles presenting results from human studies (prospective, retrospective, cohort, and case-control studies), systematic reviews, and meta-analyses that examined the physiology, pathology, or genetic regulation of aldosterone or the renin-angiotensin-aldosterone system. Cases, studies without raw data, and studies with fewer than 10 participants were excluded. According to the presented data, the role of disturbances in the genetic mechanisms of aldosterone synthesis and degradation was substantiated for improving the accuracy of early diagnosis of metabolic disorders of the renin-angiotensin-aldosterone system components. Results. According to the literature, activation of the mineralocorticoid-mediated gene translation pathway depends on the genomic action of aldosterone, whereas the conventional translation pathway is associated with non-genomic effects of aldosterone. Mutations in the relevant genes are responsible for the development of pathologies and various diseases. Associations of HSD3B1 and CYP11A1 variants with blood pressure are noted, and an association of CYP11A1 rs11638442 with serum cholesterol levels and daytime diastolic blood pressure is observed.
No takes yet. Share an insight, caveat, or question.
Mylostyva et al. (2026) conducted a review in Aldosterone metabolism disorders and renin-angiotensin-aldosterone system dysfunction. Genetic variants in aldosterone synthesis and degradation pathways (e.g., STAR, CYP11A1, HSD3B1, CYP21A2, CYP11B1, CYP11B2, UGT2B7) was evaluated on Physiological and pathological effects of aldosterone and associations of genetic variants with blood pressure, serum cholesterol, and left ventricular mass (p=≤0.017). Genetic variants in HSD3B1 and CYP11A1 are associated with blood pressure and serum cholesterol, with CYP11A1 TCG haplotype carriers showing lower left ventricular mass.
Synapse has enriched 10 related papers. Consider them for comparative context: